With the help of internal FDA emails, citizens can read how pre-emption language was inserted into FDA rules to benefit big business, despite objections, while headed by an industry lawyer who took the revolving door back into industry. Monday, the U.S. Supreme Court will decide on a case shaped by pre-emption, the outcome of which potentially affects the health and safety of all citizens for years to come.